Literature DB >> 17625153

Links between triglyceride levels, hepatitis C virus infection and diabetes.

Chia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, Ming-Lung Yu, Wan-Long Chuang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17625153      PMCID： PMC1955513     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

Authors:  L Serfaty; T Andreani; P Giral; N Carbonell; O Chazouillères; R Poupon
Journal:  J Hepatol       Date:  2001-03       Impact factor: 25.083

2.  Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.

Authors:  Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang; Shinn-Cherng Chen; Li-Po Lee; Ming-Yen Hsieh; Nai-Jen Hou; Zu-Yau Lin; Jee-Fu Huang; Ming-Yuh Hsieh; Liang-Yen Wang; Ming-Lung Yu
Journal:  J Infect Dis       Date:  2005-11-16       Impact factor: 5.226

3.  Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.

Authors:  Gabriel Perlemuter; Abdelmajid Sabile; Philippe Letteron; Giovanna Vona; André Topilco; Yves Chrétien; Kazuhiko Koike; Dominique Pessayre; John Chapman; Giovanna Barba; Christian Bréchot
Journal:  FASEB J       Date:  2002-02       Impact factor: 5.191

4.  Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

Authors:  Yoshizumi Shintani; Hajime Fujie; Hideyuki Miyoshi; Takeya Tsutsumi; Kazuhisa Tsukamoto; Satoshi Kimura; Kyoji Moriya; Kazuhiko Koike
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682
  4 in total
  1 in total

1.  Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure.

Authors:  Teegan R Lim; Jonathan M Hazlehurst; Andrei I Oprescu; Matthew J Armstrong; Sewa F Abdullah; Nigel P Davies; Robert Flintham; Peter Balfe; David J Mutimer; Jane A McKeating; Jeremy W Tomlinson
Journal:  Clin Endocrinol (Oxf)       Date:  2019-01-17       Impact factor: 3.478
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.